Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort

Antonio Di Biagio; Roberta Prinapori; Diana Giannarelli; Franco Maggiolo; Simona Di Giambenedetto; Vanni Borghi; Giovanni Penco; Paola Cicconi; Daniela Francisci; Gaetana Sterrantino; Alessia Zoncada; Laura Monno; Amedeo Capetti; Andrea Giacometti

doi:10.1093/jac/dks339

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort

Antonio Di Biagio, Roberta Prinapori, Diana Giannarelli, Franco Maggiolo, Simona Di Giambenedetto, Vanni Borghi, Giovanni Penco, Paola Cicconi, Daniela Francisci, Gaetana Sterrantino, Alessia Zoncada, Laura Monno, Amedeo Capetti, Andrea Giacometti

Risultato della ricerca: Contributo in rivista › Articolo in rivista

14 Citazioni (SciVal)

Abstract

To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients.

Lingua originale	English
pagine (da-a)	200-205
Numero di pagine	6
Rivista	Journal of Antimicrobial Chemotherapy
Volume	68
DOI	https://doi.org/10.1093/jac/dks339
Stato di pubblicazione	Pubblicato - 2013

Keywords

first-line therapy tenofovir emtricitabine atazanavir/ritonavir

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1093/jac/dks339

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

Di Biagio, A., Prinapori, R., Giannarelli, D., Maggiolo, F., Di Giambenedetto, S., Borghi, V., Penco, G., Cicconi, P., Francisci, D., Sterrantino, G., Zoncada, A., Monno, L., Capetti, A., & Giacometti, A. (2013). Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. Journal of Antimicrobial Chemotherapy, 68, 200-205. https://doi.org/10.1093/jac/dks339

@article{40985da71a6441fb9886ddd2d41aba2b,

title = "Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort",

abstract = "To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients.",

keywords = "first-line therapy tenofovir emtricitabine atazanavir/ritonavir, first-line therapy tenofovir emtricitabine atazanavir/ritonavir",

author = "{Di Biagio}, Antonio and Roberta Prinapori and Diana Giannarelli and Franco Maggiolo and {Di Giambenedetto}, Simona and Vanni Borghi and Giovanni Penco and Paola Cicconi and Daniela Francisci and Gaetana Sterrantino and Alessia Zoncada and Laura Monno and Amedeo Capetti and Andrea Giacometti",

year = "2013",

doi = "10.1093/jac/dks339",

language = "English",

volume = "68",

pages = "200--205",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "1460-2091",

publisher = "Oxford University Press:Journals Department, Great Clarendon Street, Oxford OX2 6DP United Kingdom:011 44 1865 556767, EMAIL: [email protected], INTERNET: http://www.oup.co.uk, Fax: 011 44 1865 267485",

}

Di Biagio, A, Prinapori, R, Giannarelli, D, Maggiolo, F, Di Giambenedetto, S, Borghi, V, Penco, G, Cicconi, P, Francisci, D, Sterrantino, G, Zoncada, A, Monno, L, Capetti, A & Giacometti, A 2013, 'Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort', Journal of Antimicrobial Chemotherapy, vol. 68, pagg. 200-205. https://doi.org/10.1093/jac/dks339

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort. / Di Biagio, Antonio; Prinapori, Roberta; Giannarelli, Diana et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 68, 2013, pag. 200-205.

Risultato della ricerca: Contributo in rivista › Articolo in rivista

TY - JOUR

T1 - Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort

AU - Di Biagio, Antonio

AU - Prinapori, Roberta

AU - Giannarelli, Diana

AU - Maggiolo, Franco

AU - Di Giambenedetto, Simona

AU - Borghi, Vanni

AU - Penco, Giovanni

AU - Cicconi, Paola

AU - Francisci, Daniela

AU - Sterrantino, Gaetana

AU - Zoncada, Alessia

AU - Monno, Laura

AU - Capetti, Amedeo

AU - Giacometti, Andrea

PY - 2013

Y1 - 2013

N2 - To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients.

AB - To explore the durability of three first-line tenofovir/emtricitabine-based regimens in combination with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in HIV-1-infected patients.

KW - first-line therapy tenofovir emtricitabine atazanavir/ritonavir

UR - http://hdl.handle.net/10807/39904

U2 - 10.1093/jac/dks339

DO - 10.1093/jac/dks339

M3 - Article

SN - 1460-2091

VL - 68

SP - 200

EP - 205

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

ER -

Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort

Abstract

Keywords

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo